News & Press: Breaking News

US FDA User Fees Update

Tuesday, August 22, 2017  
Share |

 

US Congress passes legislation to allow for fees on prescription drugs, medical devices, generic drugs and biosimilars. The US FDA  will continue to collect fees until 2022. Read the blog post jointly written by the Directors of CBER, CDER and CDRM. 


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.